Strait Access Technologies (SAT) is a South African medical device company focused on developing innovative cardiovascular technologies to treat heart valve diseases. Founded in 2008 and based in Cape Town, the company was established by a team of clinicians, biomedical engineers, and researchers connected to the University of Cape Town and Groote Schuur Hospital. SAT’s mission is to design cost-effective medical devices that can improve access to life saving treatment for patients suffering from conditions such as rheumatic heart disease, which affects millions of people worldwide, particularly in developing countries.
The company specialises in minimally invasive trans-catheter heart valve technologies designed to reduce the need for open-heart surgery. Its research and development efforts focus on durable and affordable devices, including trans-catheter aortic valves and innovative balloon-based systems used in cardiovascular procedures. By combining advanced engineering, clinical research, and patented technologies, Strait Access Technologies aims to create scalable medical solutions that expand access to heart valve treatments and improve outcomes for patients in both developing and developed healthcare systems.